RTL-1000

N/A

Report date: 2024/01/19 15:04:05

Base Information

Drug NameRTL-1000
Drug Alias NameVG-1000RTL-1000
ClassificationBiologics
Mechanisms of ActionCluster of differentiation 47 modulators
TargetsCluster of differentiation 47
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOregon Health & Science University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArtielle Immunotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive

Other Information

ATC CodeN/A
Related LinksN/A